HYPERPLASTIC PROCESSES OF ENDOMETRIUM IN PREMENOPAUSE: IMPROVEMENT OF TREATMENT METHODS
Keywords:
hyperplastic processes of the endometrium, premenopause, combined oral contraceptives, premenstrual syndrome, treatment methodsAbstract
The purpose of the study: to improve the methods of treatment of hyperplastic processes of the endometrium.
Materials and methods: the object of the study were 40 women with hyperplastic processes and 20 control group of healthy women who underwent a complete clinical and laboratory examination with a biopsy and subsequent treatment.
Results: in the course of the study, the efficacy of treatment with Median in premenopausal women was studied, and therapeutic efficacy was found when using the drug for more than 6 cycles.
Conclusion: Long-term administration of Median is effective and prevents relapses.
References
Alimjanovich J. R., Agababyan L. R., Kamalov A. I. Prevention and Treatment of Postpartum Hemorrhage //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – Т. 2. – №. 4. – С. 204-209.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No.108. Polycystic ovary syndrome. Obstet. Gynecol. 2009; 114: 936-949.
Baak J.P., Mutter G.L., Robboy S., van Diest P.J., Uyterlinde A.M. at al. The molecular genetics and motphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than 1994 World Health Organization classification system. Cancer. 2005; 103(11): 2304-2312
Banno K.,Kisu I., Yanokura M., Tsuji K., Masuda K. at al. Progestin therapy for endometrial cancer: the potencial of fourth-generation progestin (review). Am.J.Oncol.2012; 40(6): 1755-1762
Clark T.J., Neelacantan D., Gupta J.K. The management of endometrial hyperplasia: an evaluation of current practice. Eur.J. Obstet. Gynecol. Reprod. Biol.2006; 125 (2):259-264.
Dzhurayev, M. D. ., Oripova, M. R. ., Ortikova, K. U. ., & Rakhimov, N. M. . (2021). Cytogenetic Study Of Peripheral Blood Leukocytes In Patients With Uterine Mesenchymal Tumors. The American Journal of Medical Sciences and Pharmaceutical Research, 3(06), 94–99
Endometrial hyperplasia, endometrial cancer and prevention: Gaps in existing research of modifiable risk factors /Linkov F., Edwards R., Balk J., Yurkovetsky Z., Stadterman B., Lokshin A., Taioli E.//European Journal of Cancer.2008. Vol.44. Issue 12.P. 1632-1644.
Endometrial polyps in pre- and postmenopausal women: Factors associated with malignancy /Antunes A Jr., Costa-Paiva L., Arthuso M., Costa M.J., Pinto-Neto A.M.// Maturitas.2010. Vol.57, Issue 4.P.415-421
Epplein M., Reed S.D., Voigt L.F. at al. Risk of complex atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am.J.Epidemiol.2008;168(6):563-570
Gallos I.D., Shehmar M., Thangaratinam S., Papapostolou T.K., Coomarasamy A., Gupta J.K. Oral progestogens vs levonorgestrel-realising intrauterine system for endometrial hyperplasia: a systematic review and meta-analisis. Am.J. Obstet.Gynecol.2010; 203:547; e-1-10
Gallos I.D., Ofinran O., Shehmar M., Coomarasamy A., Gupta J.K. Current management of endometrial hyperplasia – a survey of United Kindom consultant gynaecologists. Eur.J. Obstet.Gynecol. 2011;158(2);305-307
Jasur Rizayev Alimjanovich, Larisa Rubenovna Agababyan, Anvar Ibragimovich Kamalov. AYOLLARDA TUG‘RUQDAN KEYINGI QON KETISHLARNI OLDINI OLISH VA ULARGA QARSHI KURASHISH BO‘YICHA KO‘RSATILAYOTGAN XIZMATLAR SIFATINING MONITORINGINI TASHKIL ETISH// Oriental Renaissance: Innovative, educational, natural and social sciences Volume 1_ ISSUE 10, 2021 p. 166-169
ISKANDAROVNA T. N., RAKHIMOVNA K. D. RISK FACTORS FOR THE DEVELOPMENT OF ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSE //БИОМЕДИЦИНА ВА АМАЛИЁТ ЖУРНАЛИ. – С. 72.
Hongying Dai, Shuping Zhao, Lin Xu, Aiping Chen, Shuzhen Da. Expression of Efp, Vegf and FGF in normal, hyperplastic and malignant endometrial tissue. Oncol.Rep.2010; 23:795-799/
Khudoyarova D. S. D. R., Tilavova S. A., Shopulotova Z. A. MANIFESTATIONS OF EXAMINATION OF CHRONIC PYELONEPHRITIS IN PREGNANT WOMEN (CLINICAL CASE) //Thematics Journal of Microbiology. – 2022. – Т. 6. – №. 1.
Mills A.M., Longacre T.A. Endometrial hyperplasia.Semin.Diagn.Pathol.2010;27(4):199-214
Steinbakk A., Gudlaugsson E., Aasprong O.G., Skaland I. at al. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am. J. Obstet. Gynecol.2011; 204(4):357; e1-12
Тоджиева Н. И., Худоярова Д. Р., Базарова З. З. Совершенствование методов лечения гиперпластических процессов эндометрия в пременопаузе //Профессионал года. – 2018. – Т. 2018. – С. 81-84.
Тоджиева Н., Агабабян Л., Авазова Г. Современные методы лечения гиперпластических процессов эндометрия (гпэ) в перименопаузе //Журнал вестник врача. – 2014. – Т. 1. – №. 03. – С. 39-42.
Худоярова Д. Р., Шопулотова З. А. OPTIMIZATION OF MANAGEMENT OF PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2022. – Т. 3. – №. 3.
